| pubmed-article:8589027 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8589027 | lifeskim:mentions | umls-concept:C1521808 | lld:lifeskim |
| pubmed-article:8589027 | lifeskim:mentions | umls-concept:C1516985 | lld:lifeskim |
| pubmed-article:8589027 | lifeskim:mentions | umls-concept:C0146224 | lld:lifeskim |
| pubmed-article:8589027 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:8589027 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:8589027 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:8589027 | pubmed:dateCreated | 1996-3-27 | lld:pubmed |
| pubmed-article:8589027 | pubmed:abstractText | This phase II study with the topoisomerase I inhibitor topotecan was performed to determine its clinical activity and toxicity in patients with metastatic or locally unresectable colorectal cancer. | lld:pubmed |
| pubmed-article:8589027 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8589027 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8589027 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8589027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8589027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8589027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8589027 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8589027 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:8589027 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:8589027 | pubmed:author | pubmed-author:VerweijJJ | lld:pubmed |
| pubmed-article:8589027 | pubmed:author | pubmed-author:SchöffskiPP | lld:pubmed |
| pubmed-article:8589027 | pubmed:author | pubmed-author:HudsonII | lld:pubmed |
| pubmed-article:8589027 | pubmed:author | pubmed-author:DirixL YLY | lld:pubmed |
| pubmed-article:8589027 | pubmed:author | pubmed-author:CreemersG JGJ | lld:pubmed |
| pubmed-article:8589027 | pubmed:author | pubmed-author:WandersJJ | lld:pubmed |
| pubmed-article:8589027 | pubmed:author | pubmed-author:GamucciTT | lld:pubmed |
| pubmed-article:8589027 | pubmed:author | pubmed-author:VallentinSS | lld:pubmed |
| pubmed-article:8589027 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8589027 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:8589027 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8589027 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8589027 | pubmed:pagination | 844-6 | lld:pubmed |
| pubmed-article:8589027 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:meshHeading | pubmed-meshheading:8589027-... | lld:pubmed |
| pubmed-article:8589027 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8589027 | pubmed:articleTitle | Topotecan in colorectal cancer: a phase II study of the EORTC early clinical trials group. | lld:pubmed |
| pubmed-article:8589027 | pubmed:affiliation | Department of Medical Oncology, Rotterdam Cancer Institute, The Netherlands. | lld:pubmed |
| pubmed-article:8589027 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8589027 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8589027 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8589027 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8589027 | lld:pubmed |
